Alzheimer’s Disease Diagnostic Market Overview
Alzheimer’s disease is one of the common disorders in the elderly population. People getting affected by the disease are globally increasing, propelling the demand for effective diagnosis and treatment. This factor is driving the demand of the alzheimer’s disease diagnostic market.
The alzheimer’s disease diagnostic market is expected to reach a value of USD 12 billion and a CAGR of 10 % during the forecast period. The disease is associated with neurological disorders affecting a person’s memory, thinking, and activities. The situation worsens with age and time and damages most brain parts. Therefore, the people’s concern for the treatment is propelling the alzheimer’s disease diagnostic market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2149
The major growth factors driving the market are the increased number of chronic diseases such as dementia, drug development for effective treatment, and technical advancement is accelerating the market. The efforts of government and other medical and academic institutes, along with higher investments in research and development for Alzheimer’s disease Diagnostics, are helping the market elevate. The rise in the number of clinical and pathological studies is also propelling its growth.
During the Covid19 situation, the alzheimer’s disease diagnostic market was affected, disrupting the supply chain. But in the further days, the market faced good growth when the mortality rate from COVID 19 patients who were suffering from dementia increased. Patients with mental health disorders suffered a lot which has increased the market’s demand.
Alzheimer’s Disease Diagnostic Market Segmentation
The alzheimer’s disease diagnostic market is segmented into type, product type, and end-users.
The type segment of the market consists of Early-onset Alzheimer’s, Late-onset Alzheimer’s, Familial Alzheimer’s disease. The product type section is segregated into therapeutics and diagnostics. The therapeutics are further divided into Cholinesterase Inhibitors, NMDA Receptor Antagonists, and many others. At the same time, the diagnostic segment includes brain imaging and CFS testing for Alzheimer’s disease, genetic testing, neurological exam, and mini-mental state exam (MMSE). The end-users of the market are classified into clinics, hospitals, diagnostic centers, healthcare providers, government, research and development institutes, academic medical institutions, and healthcare consumers.
Alzheimer’s Disease Diagnostic Market Regional Analysis
According to the regional report, the alzheimer’s disease diagnostic market is showing its growth in prominent regions such as America, Europe, Asia-pacific, and other countries.
The American regions, including North America and Latin America, are considered the largest market due to the rise in the number of geriatric and older populations who are at higher risk of getting this disease.
The European region is capturing the second-largest alzheimer’s disease diagnostic market share due to many technological advances and huge investment in research and development activities relating to Alzheimer’s disease.
The Asia-Pacific has major countries, China, Japan, India, Australia, and South Korea, responsible for driving the regional alzheimer’s disease diagnostic market growth.
The other regions around the world, such as the Middle East and Africa, are noticing slower but constant growth due to the lower technological developments and lack of government initiatives.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149
In December 2020, C2N Diagnostics launched the “Percivity AD Blood Test” in the European regions by approval from the European government. It is a diagnostic method that is built on mass spectrometry. It is used to diagnose Alzheimer’s disease and the relating pathology labs.
Browse Related Reports at:
COVID-19 Diagnostics Market Research Report—Forecast till 2027
COVID Testing Kit Market Research Report—Forecast till 2027
ePharmacy Market Research Report—Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071